Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion

Pharmaceutical Research

Volumn 14, Issue 9, 1997, Pages 1127-1132

  Takamatsu, Narushi ^a   Welage, Lynda S ^b   Idkaidek, Nasir M ^c   Liu, Dong Yue ^d   Lee, Peter I Der ^e   Hayashi, Yayoi ^f   Rhie, Julie K ^g   Lennernäs, Hans ^h   Barnett, Jeffrey L ⁱ   Shah, Vinod P ^j   Lesko, Lawrence ^j   Amidon, Gordon L ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^f NAGOYA CITY UNIVERSITY   (Japan)

^g CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

Biopharmaceutic classification scheme; Drug absorption; Intestinal permeability; Piroxicam; Propranolol

Indexed keywords

MACROGOL 400; PHENYLALANINE; PIROXICAM; PROPRANOLOL;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; HUMAN; HUMAN EXPERIMENT; INTESTINE MUCOSA PERMEABILITY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGIONAL PERFUSION; SMALL INTESTINE ABSORPTION; VOLUNTEER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; HUMANS; JEJUNUM; MALE; PERMEABILITY; PHENYLALANINE; PIROXICAM; POLYETHYLENE GLYCOLS; PROPRANOLOL; SOLVENTS;

EID: 9844259465     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012134219095     Document Type: Article

References (24)

1. T. Z. Csaky. Intestinal permeation and permeability: an overview. In T. Z. Csaky (eds.), Pharmacology of Intestinal Permeation I, Springer-Verlag, New York, 51-59 (1984).
2. K. Ewe, R. Wanitschke, and M. Staritz. Intestinal permeability studies in humans. In T. Z. Csaky (eds.), Pharmacology of Intestinal Permeation II, Springer-Verlag, New York, 535-571 (1994).
3. H. Lennernäs, Ö. Ahrenstedt, and A. L. Ungell. Br. J. Clin. Pharmac. 37:589-596 (1994).
4. H. Lennernäs, Ö. Ahrenstedt, R. Hällgren, L. Knutson, M. Ryde, and L. K. Paalzow. Pharm. Res. 9:1243-1251 (1992).
5. R. Modigliani, J. C. Rambaud, and J. J. Bernier. Digestion 9:176-192 (1973).
6. D. C. Taylor, R. Pownall, and W. Burke. J. Pharm. Pharmacol. 37:280-283 (1985).
7. I. M. Menzies. Transmucosal passage of inert molecules in health and disease. In E. Skadhauge and K. Heintze (eds.), Intestinal Absorption and Secretion. MTP Press, Lancaster, 527-543 (1983).
8. B. G. Munck. Intestinal absorption of amino acids. In L. F. Johnson (eds.), Physiology of the Gastrointestinal Tract, Raven Press, New York, 1097-1122 (1981).
9. F. D. Boudinot and S. S. Ibrahim. J. Chromatogr. 430:424-428 (1988).
10. R. B. Gillilan, W. D. Mason, and C. J. Fu. J. Chromatogr. 487:232-235 (1989).
11. A. A. Al-Angary, Y. M. El-Sayed, M. A. Al-Meshal, M. M. Al-Dardiri and G. M. Mahrous. Journal of Clinical Pharmacy and Therapeutics 16:93-101 (1991).
12. N. D. Atherton and A. Green. Clin. Chem. 34:2241-2244 (1988).
13. C. Carducci, F. Moretti, M. Birarelli, and I. Antonozzi. J. Chromatogr. 553:149-154 (1991).
14. I. M. Kinahan and M. R. Smyth. J. Chromatogr. 565:297-307 (1991).
15. D. A. Johnson and G. L. Amidon. J. theor. Biol. 131:93-106 (1988).
16. P. J. Sinko, G. D. Leesman, and G. L. Amidon. Pharm. Res. 8:979-998 (1991).
17. G. L. Amidon, J. Kou, R. L. Elliott, and E. N. Lightfoot. J. Pharm. Sci. 69:1369-1373 (1980).
18. R. Murphy, A. C. Selden, M. Fisher, E. A. Fagan, and V. S. Chadwick. J. Chromatogr. 211:160-165 (1981).
19. P. Krugliak, D. Hollander, K. Le, T. Ma, V. D. Dadufalza, and K. D. Katz. Gut 31:417-421 (1990).
20. V. M. F. Choi, J. E. Coates, J. Chooi, A. B. R. Thomson, and A. S. Russell. Clin. Invest. Med. 18:357-361 (1995).
21. N. M. Idkaidek, G. L. Amidon, H. Lennernäs, and A. Hussain. Submitted (1997).
22. B. E. Bleske, L. S. Welage, S. Rose, G. L. Amidon, and M. J. Shea. J. Clin. Pharmacol. 35:374 (1995).
23. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. Pharm. Res. 12:413-420 (1995).
24. J. P. Skelly, G. A. Van Buskirk, H. M. Arbit, G. L. Amidon, L. Augsburger, W. H. Barr, S. Berge, J. Clevenger, S. Dighe, M. Fawzi, D. Fox, M. A. González, V. A. Gray, C. Hoilberg, L. J. Leeson, L. Lesko, H. Malinowski, P. R. Nixon, D. M. Pearce, G. Peck, S. Porter, J. Robinson, D. R. Savello, P. Schwaitz, J. B. Schwartz, V. P. Shah, R. Shangraw, F. Theeuwes, and T. Wheatley. Pharm. Res. 10:1800 (1993).